Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187

20 Mar 2020

Abstract excerpt

Breast cancer is the most common malignancy for women worldwide, while Triple Negative Breast Cancer (TNBC) accounts for 20% in all patients. Compared with estrogen receptor positive breast cancer, which could be effectively controlled via endocrine therapy, TNBC is more aggressive and worse in prognosis. It is therefore urgent and necessary to develop a novel therapeutic strategy for TNBC treatment. Recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Hippo pathway signaling and YAP/TAZ
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32198343
DOI: 10.1038/s41389-020-0220-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187PMID 32198343Read ↗

RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axisSemantic proximity Read ↗

The Hippo Pathway in Breast Cancer: The Extracellular Matrix and HypoxiaSemantic proximity Read ↗

Implications for precision medicine and the reciprocal control of microRNAs by Hippo and TAZ signaling in breast cancerSemantic proximity Read ↗

A Novel Signature of CCNF-Associated E3 Ligases Collaborate and Counter Each Other in Breast CancerSemantic proximity Read ↗

Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression MicroarraySemantic proximity Read ↗

A comprehensive pan-cancer analysis of RNF187 in human tumorsSemantic proximity Read ↗

FBXW7 in breast cancer: mechanism of action and therapeutic potentialSemantic proximity Read ↗

HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancerSemantic proximity Read ↗

Alteration of MDM2 by the Small Molecule YF438 Exerts Antitumor Effects in Triple-Negative Breast CancerSemantic proximity Read ↗

Functional characterization of FBXL7 as a novel player in human cancersSemantic proximity Read ↗

UBR7 in concert with EZH2 inhibits the TGF-β signaling leading to extracellular matrix remodelingSemantic proximity Read ↗

The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.